How injectable/oral GLP-1 medications work: Mimic the GLP-1 hormone with engineered modifications for extended duration Bind to GLP-1 receptors to enhance insulin release and reduce glucagon Slow gastric emptying by 20-50%, promoting satiety Supported by large randomized controlled trialsthe STEP trials showed 14.9% mean weight loss at 68 weeks versus 2.4% for placebo The short answer on why patches cant deliver these drugs: GLP-1 molecules are relatively large peptide chains (molecular weight 3-5 kDa) that cannot effectively penetrate the skin barrier through passive transdermal diffusion
Any impairment in kidney or liver function can significantly slow the clearance of peptides and their metabolites from the bloodstream, effectively extending their half-life
Most researchers notice appetite suppression within 24 to 72 hours of the first injection
Additionally, 36.8 percent of patients treated with Wegovy experienced improvement in fibrosis with no worsening of steatohepatitis, versus 22.4 percent in the placebo group
Monitor closely for nausea, vomiting, diarrhea, abdominal pain, or signs of hypoglycemia (especially if you take insulin or sulfonylurea medications)
It can be comfort, culture, routine, celebration, stress relief, and social connection
